Document Detail


HGF/c-Met pathway has a prominent role in mediating antiapoptotic signals through AKT in epithelial ovarian carcinoma.
MedLine Citation:
PMID:  20661229     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
The Met receptor tyrosine kinase and its ligand, hepatocyte growth factor (HGF), are overexpressed and/or activated in a variety of human malignancies. However, its role in epithelial ovarian carcinoma (EOC) has not been clearly elucidated. Therefore, we investigated the role of HGF/c-Met signaling pathway in a large series (156) of Saudi EOC patient samples, a panel of cell lines, and xenografts in a NUDE mouse model. Using immunohistochemistry, c-Met overexpression was found in 27.2% Middle Eastern EOC samples and was associated with an advanced tumor stage (P=0.0187). c-Met overexpression was also associated with antiapoptotic markers X-chromosome-linked inhibitors of apoptosis (XIAP) (P=0.0008) and Bcl-XL (P=0.0493) expression. Treatment of EOC cell lines with PHA665752 causes a dose-dependent inhibition of cell viability and induction of apoptosis. Furthermore, PHA665752 treatment causes dephosphorylation of AKT and downregulation of antiapoptotic proteins XIAP and Bcl-XL. In addition, PHA665752-induced apoptosis occurs through activation of Bax-mediated release of cytochrome c and activation of caspases. Finally, co-treatment of EOC with PHA665752 and cisplatin causes augmented effect on apoptosis of EOC cells and resulted in synergistic inhibition of EOC xenograft tumor growth in NUDE mice. These results indicate that c-Met/HGF pathway may be a potential target for therapeutic intervention for treatment of EOC.
Authors:
Rong Bu; Shahab Uddin; Prashant Bavi; Azhar R Hussain; Fouad Al-Dayel; Samir Ghourab; Maqbool Ahmed; Khawla S Al-Kuraya
Related Documents :
9124039 - Model systems of epithelium-mesenchyme transitions.
15528389 - Immune responses of breast cancer patients to mutated epidermal growth factor receptor ...
12829999 - Ppargamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent gadd45 a...
14964469 - Immunohistochemical study of genesis of the mouse oral vestibule.
10502499 - Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme act...
19578789 - Reciprocal regulation of il-6 and il-10 balance by hgf via recruitment of heme oxygenas...
21113099 - Immunomodulatory effects of betulinic acid from the bark of white birch on mice.
19199909 - Reducing the immunogenicity of protein therapeutics.
15275969 - The expression of b7-h1 on keratinocytes in chronic inflammatory mucocutaneous disease ...
Publication Detail:
Type:  Journal Article     Date:  2010-07-26
Journal Detail:
Title:  Laboratory investigation; a journal of technical methods and pathology     Volume:  91     ISSN:  1530-0307     ISO Abbreviation:  Lab. Invest.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376617     Medline TA:  Lab Invest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  124-37     Citation Subset:  IM    
Affiliation:
Human Cancer Genomic Research, Research Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway.
Next Document:  Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and ...